Picture of Standard BioTools logo

LAB — Standard BioTools News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Brief: Fluidigm Announces Preliminary Revenue Exceeding Guidance For The Fourth Quarter And Full Year 2021

Jan 11 (Reuters) - Fluidigm Corp  FLDM.O :
    * FLUIDIGM ANNOUNCES PRELIMINARY REVENUE EXCEEDING GUIDANCE
FOR
THE FOURTH QUARTER AND FULL YEAR 2021
    * FLUIDIGM CORP - Q4 PRELIMINARY REVENUE OF $38.0 TO $38.3
MILLION
    * FLUIDIGM CORP - FULL YEAR 2021 PRELIMINARY REVENUE OF
$130.3 TO
$130.6 MILLION

Source text for Eikon:  ID:nGNX5bbnNF 
Further company coverage:  FLDM.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Standard BioTools

See all news